IHH shares trade at expensive valuations - Public Investment

IHH Healthcare Bhd shares are trading at expensive valuations, prompting public investment bank to maintain its "neutral" call on stock. The research house's target price remains unchanged at RM4.50, pegged to FY15 blended EV / Ebitda Valuations. It said the group will continue to see strong revenue growth underpinned by its capacity expansion, especially as more beds are added in 2015.